NCT02101411View on ClinicalTrials.gov

Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)

CompletedOBSERVATIONAL

Enrollment

334

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

May 1, 2016

Study Completion Date

October 1, 2016

Conditions

PRU(Platelet Reactivity Unit)APT(Antiplatelet Therapy)HOTPR(High on Treat Platelet Reactivity)

Interventions

DIAGNOSTIC_TEST

PRU(Platelet reactivity unit)

measure by VeryfyNow.

Trial Locations (1)

Unknown

Taipei City Hospital, Taipei

All Listed Sponsors

lead

Taipei City Hospital

OTHER_GOV

NCT02101411 - Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention) | Biotech Hunter | Biotech Hunter